Transvenous phrenic nerve stimulation (TPNS) has been identified as a potential treatment option for patients with central sleep apnea and heart failure. Upon analysis of the Remedē system pivotal trial, it was discovered that the use of TPNS resulted in a significantly higher chance of improved clinical outcomes for these patients. This article aims to
Health
The FDA has recently issued a warning letter to Safari Stem Cell, a Texas-based company that produces stem cell and platelet-rich plasma products for pets. The agency raised concerns about the company’s claims that its products can treat a variety of diseases in animals, including arthritis, kidney disease, dry eye, and intervertebral disc disease. These
Insomnia has long been associated with a myriad of health issues, but a recent 5-year longitudinal study conducted in Canada has shed light on the significant connection between insomnia and depression. The study, presented at the annual SLEEP meeting, revealed that individuals with insomnia are at a greater risk of developing depression over time. This
Dozens of passengers who recently returned from an international cruise experienced an unknown illness while on a flight to Houston. This incident highlights the potential health risks associated with international travel, especially in the midst of a global pandemic. Dr. Anthony Fauci, a prominent figure in the country’s COVID response, is set to testify before
Diffuse large B-cell lymphoma (DLBCL) is a challenging type of cancer to treat, especially in cases of relapse or refractory disease. However, a recent interim analysis of the phase III ECHELON-3 trial revealed some promising results in the third-line setting. This study investigated the use of a triplet combination therapy involving brentuximab vedotin (BV), lenalidomide,
The United States is currently facing a critical nursing shortage that is expected to worsen in the coming years. As a healthcare professional with years of experience in the field, I have witnessed firsthand the impact of this shortage on our healthcare system. Despite the increasing demand for nursing care as our population ages, there
Xenotransplantation, the process of transplanting organs from one species to another, has long been a topic of both hope and controversy in the medical field. Recent advancements in genetic editing have brought new possibilities for using animal organs, particularly pig organs, to address the critical shortage of human donors for organ transplants. However, as recent
Chronic inflammatory demyelinating polyneuropathy (CIDP) is a complex disease that often goes undiagnosed or misdiagnosed due to its rarity and heterogeneity. Current standard treatments like intravenous immunoglobulin (IVIG), steroids, and plasma exchange have limitations in some CIDP phenotypes, making the need for valid biomarkers crucial. Dr. Jeffrey Allen of the University of Minnesota highlights the
The recent warning issued by the FDA to Akan Biosciences, the maker of an allogenic, adipose-derived stromal vascular fraction (SVF) product, sheds light on the regulatory challenges faced by companies in the field of regenerative medicine. This article aims to analyze the FDA’s warning to Akan Biosciences and explore the implications for the broader regenerative
A recent study conducted in Sweden revealed some concerning findings regarding premenstrual disorders (PMDs) and their association with mortality risk among women. While the study did not find an increased risk of overall mortality among women with PMDs, it did identify a higher risk of death from nonnatural causes, particularly suicide. This highlights the need